ChREBP Activators
The captivating realm of ChREBP activators unfolds as a sophisticated dance of compounds intricately choreographing the activation of Carbohydrate-Responsive Element-Binding Protein (ChREBP) and shaping the intricate landscape of lipid metabolism. Despite not engaging directly with ChREBP, these activators emerge as pivotal players in cellular pathways that converge on ChREBP activation, presenting a nuanced perspective on the orchestration of metabolic regulation. Within this chemical ensemble, MG-132 takes center stage as a proteasome inhibitor, ingeniously indirect in its activation of ChREBP by thwarting its degradation. This inhibition initiates a cascade of events, culminating in the accumulation of ChREBP and its subsequent translocation to the nucleus, unfolding a pivotal act in the metabolic drama. AICAR and Berberine, both AMP-activated protein kinase (AMPK) activators, artfully exert their influence by disrupting ATP production. This activation of AMPK sets in motion downstream events that choreograph the activation of ChREBP, finely tuning the transcription of lipogenic genes crucial for lipid metabolism.
The ballet of nuclear receptors comes to life in this intricate dance, with compounds such as GW6471, GW7647, and Rosiglitazone elegantly modulating the activities of PPARα, PPARδ, and PPARγ, respectively. These interactions subtly shape ChREBP activation, showcasing the integration of diverse signaling pathways in the grand metabolic orchestration. Oltipraz, a Nrf2 activator, introduces an additional layer to the performance by influencing Nrf2 signaling, further promoting ChREBP activation and enhancing the symphony of lipid metabolism. In concert, ChREBP activators reveal a refined network of compounds orchestrating ChREBP activity through diverse pathways, emphasizing the intricate interplay within metabolic regulation. Understanding these elaborate orchestrations offers valuable insights into potential strategies for addressing metabolic disorders where dysregulated lipid metabolism takes center stage. The beauty of this choreography lies not only in its complexity but in the potential it holds for interventions tailored to the intricate dance of metabolic balance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a proteasome inhibitor, indirectly activates ChREBP by preventing its degradation. This inhibition allows the accumulation of ChREBP, promoting its translocation to the nucleus and enhancing the transcription of lipogenic genes crucial for lipid metabolism. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMP-activated protein kinase (AMPK) activator, indirectly activates ChREBP by inhibiting ATP production. AMPK activation triggers downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes vital for lipid metabolism. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a SIRT1 activator, indirectly activates ChREBP by modulating SIRT1 activity. This modulation influences downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes crucial for lipid metabolism. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine, an AMP-activated protein kinase (AMPK) activator, indirectly activates ChREBP by inhibiting ATP production. AMPK activation triggers downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes vital for lipid metabolism. | ||||||
GW6471 | 880635-03-0 | sc-300779 | 5 mg | $295.00 | 9 | |
GW6471, a PPARα antagonist, indirectly activates ChREBP by inhibiting PPARα. This inhibition influences downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes crucial for lipid metabolism. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $49.00 $170.00 $267.00 $661.00 | 6 | |
GW7647, a PPARδ agonist, indirectly activates ChREBP by modulating PPARδ activity. This modulation influences downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes vital for lipid metabolism. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz, a Nrf2 activator, indirectly activates ChREBP by influencing Nrf2 signaling. This influence promotes ChREBP activation and enhances the transcription of lipogenic genes crucial for lipid metabolism. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin, an AMP-activated protein kinase (AMPK) activator, indirectly activates ChREBP by inhibiting ATP production. AMPK activation triggers downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes vital for lipid metabolism. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly activates ChREBP by influencing DNA methylation. This influence promotes ChREBP activation and enhances the transcription of lipogenic genes crucial for lipid metabolism. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, indirectly activates ChREBP by modulating PPARγ activity. This modulation influences downstream events, promoting ChREBP activation and enhancing the transcription of lipogenic genes vital for lipid metabolism. | ||||||